Gleacher & Company Welcomes Another Addition to Equity Healthcare Team

Published in Stocks and Investing on Friday, September 3rd 2010 at 14:16 GMT by Market Wire
^{🞛 This publication is a summary or evaluation of another publication}

NEW YORK--([ BUSINESS WIRE ])--Gleacher & Company Securities, Inc., a broker-dealer subsidiary of Gleacher & Company, Inc. (Nasdaq: GLCH), today announced another addition to its Healthcare Research team with the hiring of Ying Huang.

"I continue to believe that expanding our equity platform is a critical element in our overall growth initiative. Adding Ying to our existing Healthcare Team is a meaningful step toward capitalizing on the opportunities that we see in Healthcare."

Mr. Huang joins Gleacher & Company from Credit Suisse where he covered Biotechnology companies across all market capitalizations. Prior to working on Wall Street, Mr. Huang spent 10 years at the Schering-Plough Research Institute where he was a Principal Scientist in the drug discovery and development area. He received his PhD in Bio-Organic Chemistry from Columbia University and completed his undergraduate work at the University of Science and Technology of China.

Robert Meier, Head of Gleacher & Companya�s Equity division, said, aWe are thrilled to have Ying join our team. Adding a biotech analyst with such deep scientific knowledge will enhance our product offering to our clients. We are committed to establishing a strong Healthcare research vertical and our well respected team of Amit Hazan, Joe France, Sung Ji Nam, and now Ying Huang will form the nucleus of Gleacher Healthcare.a

Eric Gleacher, Chief Executive Officer of Gleacher & Company, said, aI continue to believe that expanding our equity platform is a critical element in our overall growth initiative. Adding Ying to our existing Healthcare Team is a meaningful step toward capitalizing on the opportunities that we see in Healthcare.a

About Gleacher & Company

Gleacher & Company, Inc. (Nasdaq: GLCH) is an independent, full service investment bank that provides corporate and institutional clients with strategic, research-based investment opportunities, capital raising, and financial advisory services, including merger and acquisition, restructuring, recapitalization, and strategic alternative analysis, as well as securities brokerage services. For more information, please visit [ www.gleacher.com ].

Forward Looking Statements

This press release contains aforward-looking statements.a These statements are not historical facts but instead represent the Companya�s belief regarding future events, many of which, by their nature, are inherently uncertain and outside of the Companya�s control. The Companya�s forward-looking statements are subject to various risks and uncertainties, including the conditions of the securities markets, generally, and acceptance of the Companya�s services within those markets and other risks and factors identified from time to time in the Companya�s filings with the Securities and Exchange Commission. It is possible that the Companya�s actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in its forward-looking statements. You are cautioned not to place undue reliance on these forward-looking statements. The Company does not undertake to update any of its forward-looking statements.

Publication Contributing Sources

Market Wire

N@N

Gleacher & Company Welcomes Another Addition to Equity Healthcare Team